News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Vertex Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Business
Vertex Coughs Up $105 Million Upfront to CRISPR for Gene Editing Pact
October 26, 2015
·
2 min read
Genetown
Vertex’s Success Spurs Startups Corbus and Pulmatrix to Enter Cystic Fibrosis Market
August 18, 2015
·
2 min read
Job Trends
Vertex Renegotiates Tax Deal With City of Boston, Ready to Rebound and Start Hiring
August 12, 2015
·
2 min read
Deals
Watch Out Gilead, Investors Feel Vertex May Be Biogen’s Good Fit
July 31, 2015
·
3 min read
Business
Ex-Vertex Digs Get Two New Biotech Tenants in CRISPR and Synologic
July 30, 2015
·
2 min read
Deals
Four Boston Biotechs That Could Make M&A Moves This Year
July 30, 2015
·
3 min read
Genetown
The Secret To Vertex’ Success
July 29, 2015
·
1 min read
FDA
Vertex Gets FDA Approval for $259K Per Year CF Drug
July 6, 2015
·
3 min read
Business
Vertex Poised to Become Profitable Following Expected FDA Approval of Orkambi
June 30, 2015
·
5 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - January 11, 2026
January 12, 2026
·
14 min read
Press Releases
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
December 23, 2025
·
1 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
December 8, 2025
·
15 min read
Press Releases
Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3
November 20, 2025
·
1 min read
Press Releases
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week
November 10, 2025
·
11 min read
Press Releases
Vertex Reports Third Quarter 2025 Financial Results
November 3, 2025
·
20 min read
Press Releases
Vertex to Participate in the UBS Global Healthcare Conference on November 11
October 28, 2025
·
1 min read
Press Releases
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
October 24, 2025
·
15 min read
Press Releases
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
October 20, 2025
·
10 min read
